Physiomics (PYC)

Sector:

Health Care

Index:

FTSE AIM All-Share

 4.60p
   
  • Change Today:
      0.000p
  • 52 Week High: 5.55
  • 52 Week Low: 2.10
  • Currency: UK Pounds
  • Shares Issued: 97.42m
  • Volume: 0
  • Market Cap: £4.48m
  • RiskGrade: 504

Physiomics Overview

Physiomics’ vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -43.3% -32.3%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 5.4 4.4
Pr/Book 4.6  
Latest F'cast
Revenue 18.2% 12.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Physiomics Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-18 0.43 (0.26) (31.00)p n/a n/a n/a n/a 0.0%
30-Jun-19 0.72 (0.20) (0.14)p n/a n/a n/a n/a 0.0%
30-Jun-20 0.80 (0.13) (0.09)p n/a n/a n/a n/a 0.0%
30-Jun-21 0.70 (0.34) (0.22)p n/a n/a n/a n/a 0.0%
30-Jun-22 0.83 (0.36) (0.26)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Physiomics Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-23 0.93 (0.30) (0.19)p n/a n/a n/a n/a 0.0%
30-Jun-24 1.10 (0.25) (0.13)p n/a n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Physiomics Company Announcements

Contract announcement 11-Jan-2023 07:00 RNS
Completion of PARTNER study 09-Jan-2023 07:00 RNS
Result of AGM 22-Nov-2022 16:00 RNS

Latest Physiomics Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Physiomics Market Data

Currency UK Pounds
Share Price 4.60p
Change Today 0.000p
% Change 0.00 %
52 Week High 5.55
52 Week Low 2.10
Volume 0
Shares Issued 97.42m
Market Cap £4.48m
RiskGrade 504

Physiomics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.87% below the market average23.87% below the market average23.87% below the market average23.87% below the market average23.87% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Price Trend
7.88% above the market average7.88% above the market average7.88% above the market average7.88% above the market average7.88% above the market average
43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average
Income Not Available
Growth
9.43% below the market average9.43% below the market average9.43% below the market average9.43% below the market average9.43% below the market average
8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average

Physiomics Dividends

No dividends found

Trades for --2023

Time Volume / Share Price
0 @ 0.000p

Physiomics Key Personnel

COO Christophe Chassagnole

Top of Page